As the main effector molecule of NK cells, IFN-γ has been proved to induce CSC plasticity in breast cancer, which contributes not only to chemotherapy and target therapy resistance but also to immunotherapy resistance [19]. The gene discussed is IFNG; the disease is breast cancer.